Abstract

IntroductionEpidemiological studies suggest three daily servings of whole-grain foods (WGF) might lower cardiovascular disease risk, at least partly by lowering serum lipid levels. We have assessed the effects of consuming three daily portions of wholegrain food (provided as wheat or a mixture of wheat and oats) on lipoprotein subclass size and concentration in a dietary randomised controlled trial involving middle aged healthy individuals.MethodsAfter a 4-week run-in period on a refined diet, volunteers were randomly allocated to a control (refined diet), wheat, or wheat + oats group for 12 weeks. Our servings were determined in order to significantly increase the intakes of non starch polysaccharides to the UK Dietary Reference Value of 18 g per day in the whole grain groups (18.5 g and 16.8 g per day in the wheat and wheat + oats groups respectively in comparison with 11.3 g per day in the control group). Outcome measures were serum lipoprotein subclasses' size and concentration. Habitual dietary intake was assessed prior and during the intervention. Of the 233 volunteers recruited, 24 withdrew and 3 were excluded.ResultsAt baseline, significant associations were found between lipoprotein size and subclasses' concentrations and some markers of cardiovascular risk such as insulin resistance, blood pressure and serum Inter cellular adhesion molecule 1 concentration. Furthermore, alcohol and vitamin C intake were positively associated with an anti-atherogenic lipoprotein profile, with regards to lipoprotein size and subclasses' distribution. However, none of the interventions with whole grain affected lipoprotein size and profile.ConclusionOur results indicate that three portions of wholegrain foods, irrelevant of the type (wheat or oat-based) do not reduce cardiovascular risk by beneficially altering the size and distribution of lipoprotein subclasses.Trial Registration www.Controlled-Trials.com ISRCTN 27657880.

Highlights

  • Epidemiological studies suggest three daily servings of whole-grain foods (WGF) might lower cardiovascular disease risk, at least partly by lowering serum lipid levels

  • Most studies examining the effect of oats on cardiovascular disease (CVD) risk markers have been limited as they have used a wheat product as control [13,14,15] which does not allow the discrimination between the effects of refined or whole-grain wheat

  • Serum lipid concentrations were similar between the groups, excepted for triglycerides which were significantly higher in the refined group compared with the wheat group, due to dissimilarities between male volunteers in these two groups

Read more

Summary

Introduction

Epidemiological studies suggest three daily servings of whole-grain foods (WGF) might lower cardiovascular disease risk, at least partly by lowering serum lipid levels. Other foods containing high amount of soluble fibres, are effective in reducing plasma total and low density lipoprotein (LDL) cholesterol [8,9,10]. Unlike wheat they do not alter triglyceride (TAG) levels [11]. A small scale study has suggested that oats effectively lower small, dense LDL cholesterol concentration and particle number without producing adverse changes in TAG or HDL-concentrations in middle-aged men [13] Such an effect would partly explain why whole-grain could be beneficial against heart disease without changing total lipid profile. A study that directly compares only whole grain wheat with refined wheat foods and oat-enriched diets is critical in order to elucidate the effects of these different grains on lipoprotein subclasses size and distribution

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call